For thirteen years now, Instar – Employer Branding Agency has carried out yearly research, asking who is the most attractive employer for university students, vocational school students and long-term employees.

The survey is also carried out among law students, and for the sixth year in a row, we were in the TOP3 law firm to be nominated as the most desired place to work in the legal market.

LEXTAL advised Danish company Danfoss ACQ A/S and German company SEMIKRON INTERNATIONAL GmbH in acquiring approval for a merger from the national competition authority. Danfoss Group acquired a majority shareholding in SEMIKRON INTERNATIONAL GmbH.

The Danfoss Group is active in the manufacture and supply of hydraulic systems and hydraulic components, to a lesser extent electro-hydraulics and to an even lesser extent electrical components; the production of integrated, energy-efficient heating and cooling solutions, and the manufacture and distribution of various systems (e.g. low-voltage drives, decentral drives, system modules, enclosed drives, harmonic mitigation filters, motion control and servo drives and medium-voltage drives).

IFLR1000, a research firm of leading financial and business law firms and lawyers, published the results of its annual survey at the end of last month. The 2022 ranking also recognized the LEXTAL team, specifically in the field of financial and corporate law.

LEXTAL has been mentioned in the IFLR1000 rankings before. Last year, Ants Karu, the head of corporate law and transactions, was also given special recognition and was named as highly regarded. Customer feedback speaks for itself:

Our attorney Kaisa-Maria Kubpart and partner and attorney-at-law Kristi Sild wrote a guest chapter for the EQS Group’s Expert Guide on Whistleblowing Laws in the EU. The Guide focuses on implementing the EU Whistleblowing Directive in the EU Member States. While the Directive had to be transposed into national law by 17 December 2021, a deadline that most EU member states failed to meet, EQS Group worked with its expert partner network, including LEXTAL, across the EU to paint the most comprehensive picture possible of the situation across the continent in mid-2022. 

On May 1, a novel vaccine insurance law came into force in Estonia. Under the new law, a patient or their relatives can apply for compensation for personal injury caused by severe vaccination-related complications. LEXTAL’s attorneys-at-law Olavi-Jüri Luik and Rauno Kinkar played a key role in drafting the vaccine insurance law (medicines act).

Below is an intro to why the new insurance model is necessary and also how to apply for compensation in case of side effects.

Why Vaccine Insurance?

Severe complications from vaccination are statistically infrequent. However, side effects still exist. The advantage of vaccine insurance is that it helps to reduce people’s fears about vaccination. To lessen these fears, vaccine insurance has been introduced in about 30 countries worldwide. The advantage of insurance is that a person does not have to enter into a dispute with a vaccine manufacturer who is economically more capable and as such a difficult opponent.

The safety of COVID-19 vaccines is very high – serious injuries are rare. For example, as of the morning of 22 November, more than 1.6 million doses of vaccine had been administered in Estonia, of which only 0.37% of doses (5950 notifications) were reported to the State Agency of Medicines regarding all possible side effects and vaccine ineffectiveness. There are even fewer reports – 237 – describing at least one serious suspected adverse reaction with a temporal relationship. The most common side effects are pain at the injection site, tiredness, and fever, which go away on their own within a few days.